Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 238

1.

Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocations.

Arber DA, Slovak ML, Popplewell L, Bedell V, Ikle D, Rowley JD; International Workshop on Leukemia Karyotype and Prior Therapy..

Am J Clin Pathol. 2002 Feb;117(2):306-13.

2.
3.
4.
5.

t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia.

Rubin CM, Larson RA, Anastasi J, Winter JN, Thangavelu M, Vardiman JW, Rowley JD, Le Beau MM.

Blood. 1990 Dec 15;76(12):2594-8.

6.

Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.

Tamura S, Takemoto Y, Hashimoto-Tamaoki T, Mimura K, Sugahara Y, Senoh J, Furuyama JI, Kakishita E.

Int J Oncol. 1998 Jun;12(6):1259-62.

PMID:
9592183
7.

21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop.

Slovak ML, Bedell V, Popplewell L, Arber DA, Schoch C, Slater R.

Genes Chromosomes Cancer. 2002 Apr;33(4):379-94.

PMID:
11921272
8.

Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).

Baer MR, Stewart CC, Lawrence D, Arthur DC, Byrd JC, Davey FR, Schiffer CA, Bloomfield CD.

Blood. 1997 Aug 15;90(4):1643-8.

9.

Two different classes of therapy-related and de-novo acute myeloid leukemia?

Pedersen-Bjergaard J, Philip P.

Cancer Genet Cytogenet. 1991 Aug;55(1):119-24. Review.

PMID:
1655239
10.

Genetic analysis of 8;21 chromosomal translocation without AML1 gene involvement in MDS-AML.

Kawano S, Miyanishi S, Shimizu K, Tanaka K, Okumura A, Ohki M, Kamada N, Ohno Y.

Br J Haematol. 1997 Dec;99(3):632-40.

PMID:
9401077
11.

Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia.

Lin P, Medeiros LJ, Yin CC, Abruzzo LV.

Cancer Genet Cytogenet. 2006 Apr 1;166(1):82-5.

PMID:
16616115
12.

Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count.

Chan GC, Wang WC, Raimondi SC, Behm FG, Krance RA, Chen G, Freiberg A, Ingram L, Butler D, Head DR.

Leukemia. 1997 Feb;11(2):206-11. Review.

PMID:
9009082
13.

Immunophenotypic characteristics of acute leukaemia after myelodysplastic syndromes.

Lima M, Teixeira Mdos A, Morais S, Cunha M, Coutinho J, Pinho L, Ribeiro P, Justiça B.

Sangre (Barc). 1995 Feb;40(1):49-52.

PMID:
7716672
14.

Myelodysplastic syndrome with translocation (8;21): a distinct myelodysplastic syndrome entity or M2-acute myeloid leukemia with extensive myeloid maturation?

Kojima K, Omoto E, Hara M, Sasaki K, Katayama Y, Nawa Y, Kimura Y, Azuma T, Takimoto H, Harada M.

Ann Hematol. 1998 Jun;76(6):279-82. Review.

PMID:
9692817
15.
17.

Translocations between the long arms of chromosomes 1 and 5 in hematologic malignancies are strongly associated with neoplasms of the myeloid lineages.

Johansson B, Brøndum-Nielsen K, Billström R, Schiødt I, Mitelman F.

Cancer Genet Cytogenet. 1997 Dec;99(2):97-101.

PMID:
9398862
18.
19.
Items per page

Supplemental Content

Support Center